There are literally thousands of old, U.S. Food and Drug Administration (FDA) approved drugs that may have other potential uses besides the conditions for which they were approved. The trouble it: nobody has the profit motive to fully investigate them. Even when there are studies the FDA is suspect. The agency understands there will be little monitoring or follow-up studies reviewing long-term efficacy.
This is Dr. Stanley Goldfarb in the Wall Street Journal:
The National Library of Medicine database shows more than 2,700 recent papers on “racism and medicine,” which generally purport to show physician bias leading to racial disparities in health outcomes. Yet the most commonly cited studies are shoddily designed, ignore such critical factors as pre-existing conditions, or reach predetermined and sensationalized conclusions that aren’t supported by reported results. These papers in turn are used to source even more shoddy research.
Nearly two-thirds of adults (62%) take at least one prescription drug. Of Americans on a drug, nearly one-third (30%) report either not filling a prescription or not taking it as directed due to the cost. Even people with prescription drug coverage often find drug copays are costly. According to Kaiser Family Foundation, the average copay for a generic drug is only $12 but many copays are much higher.
Will 10,000 steps a day make you healthier? No. 7,000 steps seems to get the job done.
How did the Middle Ages respond to the Back Death? With price controls and more. (recommended)